Search Results - DATA MANAGEMENT

21

Development and validation of a drug adherence index for COPD

by Bancroft, T., Bengtson, L.G.S, Buikema, A.R, Schilling, C., Stanford, R.H
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
22

Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: An administrative claims analysis

by Chawla, A., Cook, K., Croteau, S.E, Hinds, D., Kim, B., Sammon, J., Sheikh, L., Solari, P., Thornburg, C.D
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
23

Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes

by Gionfriddo, M.R, Johns, A., Kheloussi, S., McLay, W., Parente, V.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
24

The direct and indirect costs of adult atopic dermatitis

by Bonafede, M., Boytsov, N., Brouillette, M.A, Goldblum, O., Manjelievskaia, J., Onyekwere, U., Pierce, E.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
25

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States

by Chatterjee, A., Davids, M.S, Manzoor, B.S, Qendri, V., Ravelo, A., Sail, K., Shapouri, S., van de Wetering, G.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
26

Direct medical costs of obesity in the United States and the most populous states

by Biener, A., Cawley, J., Ding, Y., Gabriel Smolarz, N.B, Meyerhoefer, C., Ramasamy, A., Zvenyach, T.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
27

Identifying adherent patients to newly initiated statins using previous adherence to chronic medications

by Abughosh, S.M, Majd, Z., Mohan, A., Paranjpe, R.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
28

Qualitative exploration of factors influencing the plan selection process by Medicare beneficiaries

by Chen, Z.X, Diggs, K., Hohmann, N., Kwon, W.-S, Westrick, S.C, Zhao, Y.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
29

Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on PRODIGE-24 and APACT...

by Au, T., Biskupiak, J., Kharat, A.A, Nelson, R.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
30

Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan

by Caplan, E.O, Chiguluri, V., Goss, A., Harvey, R., Hayden, J., Kattan, M.W, Luthra, R., Pimple, P., Prewitt, T.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
31

Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries

by Brown, V.T, Doshi, J.A, Jahnke, J., Li, P., Manz, C.R, Puckett, J.T, Raman, S., Ward, M.A
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
32

Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market

by Abughosh, S., Becho-Dominguez, G., Esse, T., Mohan, A., Payne, R., Qian, J., Serna, O., Vadhariya, A., Villarreal, K.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
33

Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder

by Devine, B., Gillard, P., Oliveri, D., Sullivan, S.D, Ta, J.T, Tung, A.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article
34

Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer

by Hays, E., Le, V., Narsipur, N., Rosario, K., Tran, D.K, Wilson, L., Zhong, L.
Published 2021

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article

[1]
Prev
1
2